CCI REGISTRY EXAM • RCIS • RCS • RVS • RCES • 2026/2027 EDITION
UPDATED FOR 2026/2027 • CCI BLUEPRINT • GRADE A
CCI REGISTRY
EXAM
• ALL PATHWAYS
Verified Questions & Answers | Grade A | 100% Correct Solutions
150 VERIFIED Q&As ALL CCI PATHWAYS 100% UNIQUE BANK
• Grade A RCIS • RCS • RVS • RCES Blueprint Aligned 2026/27
Overview — This 2026/2027 updated resource contains verified exam questions and answers for the Cardiovascular
Credentialing International (CCI) registry examinations. Includes detailed rationales aligned with current CCI exam
blueprints, covering the full range of cardiovascular credentialing pathways, including Registered Cardiovascular Invasive
Specialist (RCIS), Registered Cardiac Sonographer (RCS), Registered Vascular Specialist (RVS), and Registered Cardiac
Electrophysiology Specialist (RCES).
▣ CORE CONTENT AREAS
• Pre‑Procedural Activities — Patient assessment, history review, equipment preparation, and procedural planning
• Diagnostic Procedures — Catheterization, angiography, hemodynamic monitoring, and echocardiographic techniques
• Interventional Procedures — Angioplasty, stenting, thrombectomy, and structural heart interventions
• Emergency Protocols — Recognition and management of complications, CPR, and crisis response
• Post‑Procedural Care — Recovery monitoring, hemostasis, patient education, and discharge planning
• Ultrasound Physics & Instrumentation — Doppler principles, transducer mechanics, and image optimization
• Vascular Anatomy & Hemodynamics — Cerebrovascular, venous, and arterial pathology assessment
✓ KEY FEATURES
• ✓ Actual CCI exam format — One‑part, registry‑level examinations with selected‑response and scenario‑based questions
• ✓ Verified answers with evidence‑based rationales from cardiovascular subject‑matter experts
• ✓ Complete pathway coverage — RCIS, RCS, RVS, RCES, RCCS, and RPhS
• ✓ Updated 2026/2027 CCI exam blueprint and clinical guidelines
• ✓ 100% unique questions — no repeats across the entire bank
🔹 UPDATES FOR 2026/2027
• 🔹 Reflects current CCI exam content outlines and credentialing requirements
• 🔹 Enhanced focus on clinical decision‑making and critical thinking scenarios
• 🔹 Updated interventional and diagnostic procedure guidelines
• 🔹 Incorporates new ultrasound physics and instrumentation content
CCI Registry Exam | 2026/2027 Edition | Grade A | DOCX Format | No Repeated Questions | Complete Exam Preparation
1 | CCI Cardiovascular Credentialing
, CCI REGISTRY EXAM • RCIS • RCS • RVS • RCES • 2026/2027 EDITION
———
150 VERIFIED QUESTIONS • CCI REGISTRY • 2026/2027
SECTION 1 — PRE‑PROCEDURAL ACTIVITIES
Assessment • Consent • Labs • Time‑Out • Renal Protection • Anticoagulation
1. A 52-year-old scheduled for cardiac catheterization reports latex allergy and takes metformin.
Creatinine is 1.1 mg/dL. What is the priority pre-procedural action?
A. Proceed without changes; no labs needed
B. Hold nephrotoxic/anticoagulant per protocol, verify informed consent, NPO status, allergies (iodine/shellfish/latex), renal
function, hydration plan, and medication reconciliation
C. Give full heparin pre-procedure regardless of bleeding risk
D. Cancel time-out
Correct Answer: B. Hold nephrotoxic/anticoagulant per protocol, verify informed consent, NPO status, allergies
(iodine/shellfish/latex), renal function, hydration plan, and medication reconciliation
Rationale: Pre-procedural checklist: consent, history (allergies—especially iodine/contrast, meds—metformin/anticoagulants), labs
(creatinine/eGFR, coags), NPO, IV access, pre-hydration for renal protection, equipment and time-out. Metformin hold if eGFR
<30/contrast load. Patient context (age 52, labs/values varies by scenario) emphasizes individualized application per CCI blueprint and
ACC/AHA/ASE/SVIU guidelines.
2. Before a cath lab case, the time-out must verify:
A. Only the operator's name
B. Patient identity, procedure/site, consent, allergies, labs, equipment, and team agreement per Universal Protocol
C. Only the room number
D. No verification needed
Correct Answer: B. Patient identity, procedure/site, consent, allergies, labs, equipment, and team agreement
per Universal Protocol
Rationale: WHO/Universal Protocol: patient ID, procedure, site/laterality, consent, significant issues, equipment/implants,
prophylaxis. Prevents wrong-patient/procedure. Patient context (age 59, labs/values varies by scenario) emphasizes individualized
application per CCI blueprint and ACC/AHA/ASE/SVIU guidelines.
3. For a patient with eGFR 63 mL/min undergoing contrast angiography, renal protection includes:
A. High-dose contrast without limit
B. Pre-hydration with isotonic fluids, minimal contrast volume, avoid nephrotoxins, monitor creatinine
C. Dehydration protocol
D. No action
Correct Answer: B. Pre-hydration with isotonic fluids, minimal contrast volume, avoid nephrotoxins, monitor
creatinine
Rationale: Contrast-induced AKI risk rises with low eGFR; minimize volume, hydrate, avoid NSAIDs, hold/reassess metformin, check
post-creatinine. Patient context (age 66, labs/values varies by scenario) emphasizes individualized application per CCI blueprint and
ACC/AHA/ASE/SVIU guidelines.
4. Informed consent for invasive cardiovascular procedure requires that the patient understands:
A. Only that they will be sedated
B. Nature, benefits/risks (bleeding, arrhythmia, MI, stroke, death, contrast allergy, vascular injury), alternatives, and right to
refuse; documented and witnessed
C. No risks need disclosure
D. Only benefits
Correct Answer: B. Nature, benefits/risks (bleeding, arrhythmia, MI, stroke, death, contrast allergy, vascular
injury), alternatives, and right to refuse; documented and witnessed
Rationale: Valid consent is informed and voluntary: risks, benefits, alternatives, including consequences of refusal; questions
answered, teach-back, surrogate if incapacitated. Patient context (age 73, labs/values varies by scenario) emphasizes individualized
application per CCI blueprint and ACC/AHA/ASE/SVIU guidelines.
5. Patient on warfarin (INR 1.7) for AF scheduled for elective catheterization. The correct action is:
A. Proceed regardless of INR
B. Hold/reverse per bridging protocol based on thrombotic/bleeding risk, check INR, coordinate with prescriber
C. Double warfarin dose
D. No labs needed
Correct Answer: B. Hold/reverse per bridging protocol based on thrombotic/bleeding risk, check INR,
coordinate with prescriber
CCI Registry Exam | 2026/2027 Edition | Grade A | DOCX Format | No Repeated Questions | Complete Exam Preparation
2 | CCI Cardiovascular Credentialing
, CCI REGISTRY EXAM • RCIS • RCS • RVS • RCES • 2026/2027 EDITION
Rationale: Peri-procedural anticoagulation management balances thrombosis vs bleeding; elective cases require INR within target or
holding/bridging per guidelines. Patient context (age 45, labs/values varies by scenario) emphasizes individualized application per CCI
blueprint and ACC/AHA/ASE/SVIU guidelines.
6. A 52-year-old scheduled for cardiac catheterization reports shellfish allergy with prior hives and
takes clopidogrel. Creatinine is 0.8 mg/dL. What is the priority pre-procedural action?
A. Proceed without changes; no labs needed
B. Hold nephrotoxic/anticoagulant per protocol, verify informed consent, NPO status, allergies (iodine/shellfish/latex), renal
function, hydration plan, and medication reconciliation
C. Give full heparin pre-procedure regardless of bleeding risk
D. Cancel time-out
Correct Answer: B. Hold nephrotoxic/anticoagulant per protocol, verify informed consent, NPO status, allergies
(iodine/shellfish/latex), renal function, hydration plan, and medication reconciliation
Rationale: Pre-procedural checklist: consent, history (allergies—especially iodine/contrast, meds—metformin/anticoagulants), labs
(creatinine/eGFR, coags), NPO, IV access, pre-hydration for renal protection, equipment and time-out. Metformin hold if eGFR
<30/contrast load. Patient context (age 52, labs/values varies by scenario) emphasizes individualized application per CCI blueprint and
ACC/AHA/ASE/SVIU guidelines.
7. Before a cath lab case, the time-out must verify:
A. Only the operator's name
B. Patient identity, procedure/site, consent, allergies, labs, equipment, and team agreement per Universal Protocol
C. Only the room number
D. No verification needed
Correct Answer: B. Patient identity, procedure/site, consent, allergies, labs, equipment, and team agreement
per Universal Protocol
Rationale: WHO/Universal Protocol: patient ID, procedure, site/laterality, consent, significant issues, equipment/implants,
prophylaxis. Prevents wrong-patient/procedure. Patient context (age 59, labs/values varies by scenario) emphasizes individualized
application per CCI blueprint and ACC/AHA/ASE/SVIU guidelines.
8. For a patient with eGFR 58 mL/min undergoing contrast angiography, renal protection includes:
A. High-dose contrast without limit
B. Pre-hydration with isotonic fluids, minimal contrast volume, avoid nephrotoxins, monitor creatinine
C. Dehydration protocol
D. No action
Correct Answer: B. Pre-hydration with isotonic fluids, minimal contrast volume, avoid nephrotoxins, monitor
creatinine
Rationale: Contrast-induced AKI risk rises with low eGFR; minimize volume, hydrate, avoid NSAIDs, hold/reassess metformin, check
post-creatinine. Patient context (age 66, labs/values varies by scenario) emphasizes individualized application per CCI blueprint and
ACC/AHA/ASE/SVIU guidelines.
9. Informed consent for invasive cardiovascular procedure requires that the patient understands:
A. Only that they will be sedated
B. Nature, benefits/risks (bleeding, arrhythmia, MI, stroke, death, contrast allergy, vascular injury), alternatives, and right to
refuse; documented and witnessed
C. No risks need disclosure
D. Only benefits
Correct Answer: B. Nature, benefits/risks (bleeding, arrhythmia, MI, stroke, death, contrast allergy, vascular
injury), alternatives, and right to refuse; documented and witnessed
Rationale: Valid consent is informed and voluntary: risks, benefits, alternatives, including consequences of refusal; questions
answered, teach-back, surrogate if incapacitated. Patient context (age 73, labs/values varies by scenario) emphasizes individualized
application per CCI blueprint and ACC/AHA/ASE/SVIU guidelines.
10. Patient on warfarin (INR 2.4) for AF scheduled for elective catheterization. The correct action is:
A. Proceed regardless of INR
B. Hold/reverse per bridging protocol based on thrombotic/bleeding risk, check INR, coordinate with prescriber
C. Double warfarin dose
D. No labs needed
Correct Answer: B. Hold/reverse per bridging protocol based on thrombotic/bleeding risk, check INR,
coordinate with prescriber
Rationale: Peri-procedural anticoagulation management balances thrombosis vs bleeding; elective cases require INR within target or
holding/bridging per guidelines. Patient context (age 45, labs/values varies by scenario) emphasizes individualized application per CCI
blueprint and ACC/AHA/ASE/SVIU guidelines.
CCI Registry Exam | 2026/2027 Edition | Grade A | DOCX Format | No Repeated Questions | Complete Exam Preparation
3 | CCI Cardiovascular Credentialing
UPDATED FOR 2026/2027 • CCI BLUEPRINT • GRADE A
CCI REGISTRY
EXAM
• ALL PATHWAYS
Verified Questions & Answers | Grade A | 100% Correct Solutions
150 VERIFIED Q&As ALL CCI PATHWAYS 100% UNIQUE BANK
• Grade A RCIS • RCS • RVS • RCES Blueprint Aligned 2026/27
Overview — This 2026/2027 updated resource contains verified exam questions and answers for the Cardiovascular
Credentialing International (CCI) registry examinations. Includes detailed rationales aligned with current CCI exam
blueprints, covering the full range of cardiovascular credentialing pathways, including Registered Cardiovascular Invasive
Specialist (RCIS), Registered Cardiac Sonographer (RCS), Registered Vascular Specialist (RVS), and Registered Cardiac
Electrophysiology Specialist (RCES).
▣ CORE CONTENT AREAS
• Pre‑Procedural Activities — Patient assessment, history review, equipment preparation, and procedural planning
• Diagnostic Procedures — Catheterization, angiography, hemodynamic monitoring, and echocardiographic techniques
• Interventional Procedures — Angioplasty, stenting, thrombectomy, and structural heart interventions
• Emergency Protocols — Recognition and management of complications, CPR, and crisis response
• Post‑Procedural Care — Recovery monitoring, hemostasis, patient education, and discharge planning
• Ultrasound Physics & Instrumentation — Doppler principles, transducer mechanics, and image optimization
• Vascular Anatomy & Hemodynamics — Cerebrovascular, venous, and arterial pathology assessment
✓ KEY FEATURES
• ✓ Actual CCI exam format — One‑part, registry‑level examinations with selected‑response and scenario‑based questions
• ✓ Verified answers with evidence‑based rationales from cardiovascular subject‑matter experts
• ✓ Complete pathway coverage — RCIS, RCS, RVS, RCES, RCCS, and RPhS
• ✓ Updated 2026/2027 CCI exam blueprint and clinical guidelines
• ✓ 100% unique questions — no repeats across the entire bank
🔹 UPDATES FOR 2026/2027
• 🔹 Reflects current CCI exam content outlines and credentialing requirements
• 🔹 Enhanced focus on clinical decision‑making and critical thinking scenarios
• 🔹 Updated interventional and diagnostic procedure guidelines
• 🔹 Incorporates new ultrasound physics and instrumentation content
CCI Registry Exam | 2026/2027 Edition | Grade A | DOCX Format | No Repeated Questions | Complete Exam Preparation
1 | CCI Cardiovascular Credentialing
, CCI REGISTRY EXAM • RCIS • RCS • RVS • RCES • 2026/2027 EDITION
———
150 VERIFIED QUESTIONS • CCI REGISTRY • 2026/2027
SECTION 1 — PRE‑PROCEDURAL ACTIVITIES
Assessment • Consent • Labs • Time‑Out • Renal Protection • Anticoagulation
1. A 52-year-old scheduled for cardiac catheterization reports latex allergy and takes metformin.
Creatinine is 1.1 mg/dL. What is the priority pre-procedural action?
A. Proceed without changes; no labs needed
B. Hold nephrotoxic/anticoagulant per protocol, verify informed consent, NPO status, allergies (iodine/shellfish/latex), renal
function, hydration plan, and medication reconciliation
C. Give full heparin pre-procedure regardless of bleeding risk
D. Cancel time-out
Correct Answer: B. Hold nephrotoxic/anticoagulant per protocol, verify informed consent, NPO status, allergies
(iodine/shellfish/latex), renal function, hydration plan, and medication reconciliation
Rationale: Pre-procedural checklist: consent, history (allergies—especially iodine/contrast, meds—metformin/anticoagulants), labs
(creatinine/eGFR, coags), NPO, IV access, pre-hydration for renal protection, equipment and time-out. Metformin hold if eGFR
<30/contrast load. Patient context (age 52, labs/values varies by scenario) emphasizes individualized application per CCI blueprint and
ACC/AHA/ASE/SVIU guidelines.
2. Before a cath lab case, the time-out must verify:
A. Only the operator's name
B. Patient identity, procedure/site, consent, allergies, labs, equipment, and team agreement per Universal Protocol
C. Only the room number
D. No verification needed
Correct Answer: B. Patient identity, procedure/site, consent, allergies, labs, equipment, and team agreement
per Universal Protocol
Rationale: WHO/Universal Protocol: patient ID, procedure, site/laterality, consent, significant issues, equipment/implants,
prophylaxis. Prevents wrong-patient/procedure. Patient context (age 59, labs/values varies by scenario) emphasizes individualized
application per CCI blueprint and ACC/AHA/ASE/SVIU guidelines.
3. For a patient with eGFR 63 mL/min undergoing contrast angiography, renal protection includes:
A. High-dose contrast without limit
B. Pre-hydration with isotonic fluids, minimal contrast volume, avoid nephrotoxins, monitor creatinine
C. Dehydration protocol
D. No action
Correct Answer: B. Pre-hydration with isotonic fluids, minimal contrast volume, avoid nephrotoxins, monitor
creatinine
Rationale: Contrast-induced AKI risk rises with low eGFR; minimize volume, hydrate, avoid NSAIDs, hold/reassess metformin, check
post-creatinine. Patient context (age 66, labs/values varies by scenario) emphasizes individualized application per CCI blueprint and
ACC/AHA/ASE/SVIU guidelines.
4. Informed consent for invasive cardiovascular procedure requires that the patient understands:
A. Only that they will be sedated
B. Nature, benefits/risks (bleeding, arrhythmia, MI, stroke, death, contrast allergy, vascular injury), alternatives, and right to
refuse; documented and witnessed
C. No risks need disclosure
D. Only benefits
Correct Answer: B. Nature, benefits/risks (bleeding, arrhythmia, MI, stroke, death, contrast allergy, vascular
injury), alternatives, and right to refuse; documented and witnessed
Rationale: Valid consent is informed and voluntary: risks, benefits, alternatives, including consequences of refusal; questions
answered, teach-back, surrogate if incapacitated. Patient context (age 73, labs/values varies by scenario) emphasizes individualized
application per CCI blueprint and ACC/AHA/ASE/SVIU guidelines.
5. Patient on warfarin (INR 1.7) for AF scheduled for elective catheterization. The correct action is:
A. Proceed regardless of INR
B. Hold/reverse per bridging protocol based on thrombotic/bleeding risk, check INR, coordinate with prescriber
C. Double warfarin dose
D. No labs needed
Correct Answer: B. Hold/reverse per bridging protocol based on thrombotic/bleeding risk, check INR,
coordinate with prescriber
CCI Registry Exam | 2026/2027 Edition | Grade A | DOCX Format | No Repeated Questions | Complete Exam Preparation
2 | CCI Cardiovascular Credentialing
, CCI REGISTRY EXAM • RCIS • RCS • RVS • RCES • 2026/2027 EDITION
Rationale: Peri-procedural anticoagulation management balances thrombosis vs bleeding; elective cases require INR within target or
holding/bridging per guidelines. Patient context (age 45, labs/values varies by scenario) emphasizes individualized application per CCI
blueprint and ACC/AHA/ASE/SVIU guidelines.
6. A 52-year-old scheduled for cardiac catheterization reports shellfish allergy with prior hives and
takes clopidogrel. Creatinine is 0.8 mg/dL. What is the priority pre-procedural action?
A. Proceed without changes; no labs needed
B. Hold nephrotoxic/anticoagulant per protocol, verify informed consent, NPO status, allergies (iodine/shellfish/latex), renal
function, hydration plan, and medication reconciliation
C. Give full heparin pre-procedure regardless of bleeding risk
D. Cancel time-out
Correct Answer: B. Hold nephrotoxic/anticoagulant per protocol, verify informed consent, NPO status, allergies
(iodine/shellfish/latex), renal function, hydration plan, and medication reconciliation
Rationale: Pre-procedural checklist: consent, history (allergies—especially iodine/contrast, meds—metformin/anticoagulants), labs
(creatinine/eGFR, coags), NPO, IV access, pre-hydration for renal protection, equipment and time-out. Metformin hold if eGFR
<30/contrast load. Patient context (age 52, labs/values varies by scenario) emphasizes individualized application per CCI blueprint and
ACC/AHA/ASE/SVIU guidelines.
7. Before a cath lab case, the time-out must verify:
A. Only the operator's name
B. Patient identity, procedure/site, consent, allergies, labs, equipment, and team agreement per Universal Protocol
C. Only the room number
D. No verification needed
Correct Answer: B. Patient identity, procedure/site, consent, allergies, labs, equipment, and team agreement
per Universal Protocol
Rationale: WHO/Universal Protocol: patient ID, procedure, site/laterality, consent, significant issues, equipment/implants,
prophylaxis. Prevents wrong-patient/procedure. Patient context (age 59, labs/values varies by scenario) emphasizes individualized
application per CCI blueprint and ACC/AHA/ASE/SVIU guidelines.
8. For a patient with eGFR 58 mL/min undergoing contrast angiography, renal protection includes:
A. High-dose contrast without limit
B. Pre-hydration with isotonic fluids, minimal contrast volume, avoid nephrotoxins, monitor creatinine
C. Dehydration protocol
D. No action
Correct Answer: B. Pre-hydration with isotonic fluids, minimal contrast volume, avoid nephrotoxins, monitor
creatinine
Rationale: Contrast-induced AKI risk rises with low eGFR; minimize volume, hydrate, avoid NSAIDs, hold/reassess metformin, check
post-creatinine. Patient context (age 66, labs/values varies by scenario) emphasizes individualized application per CCI blueprint and
ACC/AHA/ASE/SVIU guidelines.
9. Informed consent for invasive cardiovascular procedure requires that the patient understands:
A. Only that they will be sedated
B. Nature, benefits/risks (bleeding, arrhythmia, MI, stroke, death, contrast allergy, vascular injury), alternatives, and right to
refuse; documented and witnessed
C. No risks need disclosure
D. Only benefits
Correct Answer: B. Nature, benefits/risks (bleeding, arrhythmia, MI, stroke, death, contrast allergy, vascular
injury), alternatives, and right to refuse; documented and witnessed
Rationale: Valid consent is informed and voluntary: risks, benefits, alternatives, including consequences of refusal; questions
answered, teach-back, surrogate if incapacitated. Patient context (age 73, labs/values varies by scenario) emphasizes individualized
application per CCI blueprint and ACC/AHA/ASE/SVIU guidelines.
10. Patient on warfarin (INR 2.4) for AF scheduled for elective catheterization. The correct action is:
A. Proceed regardless of INR
B. Hold/reverse per bridging protocol based on thrombotic/bleeding risk, check INR, coordinate with prescriber
C. Double warfarin dose
D. No labs needed
Correct Answer: B. Hold/reverse per bridging protocol based on thrombotic/bleeding risk, check INR,
coordinate with prescriber
Rationale: Peri-procedural anticoagulation management balances thrombosis vs bleeding; elective cases require INR within target or
holding/bridging per guidelines. Patient context (age 45, labs/values varies by scenario) emphasizes individualized application per CCI
blueprint and ACC/AHA/ASE/SVIU guidelines.
CCI Registry Exam | 2026/2027 Edition | Grade A | DOCX Format | No Repeated Questions | Complete Exam Preparation
3 | CCI Cardiovascular Credentialing
